|Date||27 December 2020–present|
|Cause||COVID-19 pandemic in Romania|
|Organised by||Government of Romania|
|Participants||Dose 1: 6,242,319 |
Dose 2: 5,828,457
Booster dose: 661,239
COVID-19 vaccination in Romania started on 27 December 2020. It was announced that the process would be divided into three phases. Medical personnel would be vaccinated first (first phase), followed by the population at risk (second phase), and finally by the rest of the population (third phase).Vaccination was declared free and non-mandatory. As of May 2021, four types of vaccines (Pfizer/BioNTech, Moderna, Oxford/AstraZeneca, and Janssen) were authorized to be used in Romania. This is the largest vaccination campaign in the modern history of Romania.
Former PNL Prime Minister and self-appointed coordinator of the vaccination campaign Florin Cîțu aimed to have 10.4 million people (or 70% of the country's population) vaccinated by the end of September 2021.However, by the end of September 2021, Romania had the second lowest vaccination rate in the European Union, 33%, just before Bulgaria, and sold part of its expiring vaccine stock to Denmark, Ireland, and South Korea. The low vaccination rate had exposed entrenched distrust in state institutions, misinformation campaigns, poor rural infrastructure, and weak vaccine education.
The National Coordinating Committee for COVID-19 Vaccination Activities (Romanian : Comitetul Național de Coordonare a Activităților privind Vaccinarea împotriva COVID-19; abbreviated CNCAV) is the inter-ministerial body responsible for developing the national vaccination strategy. It was established on 20 November 2020 by Prime Minister's decree and is under the direct subordination of the General Secretariat of the Government and the coordination of the Prime Minister. The first president of the Committee is Valeriu Gheorghiță, doctor at the Central Military Hospital in Bucharest.
Romania heavily relied on its military and intelligence services to set up quickly the infrastructure needed to roll out the shots throughout the country. The Romanian Army and structures from the Ministry of Interior are involved in the distribution and transport of vaccines.The online platform used for vaccine registration is also administered by an agency with military status, the Special Telecommunication Service.
Romania has ordered 120 million doses of vaccine or 7.5 doses for each person who can be vaccinated.Until 21 September 2021, it received 18.5 million doses, of which it used only about 10 million. Amid disinterest in vaccination, Romania sold or donated almost 5 million doses to countries such as Argentina, Denmark, Egypt, Ireland, Moldova, Serbia, South Korea, and Ukraine.
|Pfizer/BioNTech||US/Germany||20 million||21 December 2020||26 December 2020|
|Moderna||US||3.4 million||6 January 2021||12 January 2021|
|Oxford/AstraZeneca||UK/Sweden||N/A||29 January 2021||7 February 2021|
|Janssen||Netherlands/Israel||8 million||11 March 2021||4 May 2021|
On 26 December 2020, Ion Cantacuzino Institute in Bucharest received the first symbolic 10,000-dose batch of the Pfizer/BioNTech vaccine.The truck with the first doses of vaccine entered Romania at Nădlac customs the day before in the presence of Raed Arafat, head of the Department for Emergency Situations and Valeriu Gheorghiță, head of the National Coordinating Committee for COVID-19 Vaccination Activities. Vaccination began on 27 December in 10 infectious disease hospitals across the country, with Mihaela Anghel, a nurse at the Matei Balș National Institute for Infectious Diseases in Bucharest, being the first person vaccinated. Anghel was among the personnel that treated the country's first infected person on 27 February of the same year.
On 29 December 2020, Romanian President Klaus Iohannis announced that Romania would help Moldova with a donation of 200,000 doses of COVID-19 vaccine units in the future during his meeting with the Moldovan President Maia Sandu in the country as part of a collaboration project about the COVID-19 pandemic and other topics between the two countries.Iohannis himself was vaccinated on 15 January 2021. The first batch of COVID-19 vaccines destined to be sent to Moldova from Romania, composed of an amount of 20,000 of them, was approved by the Government of Romania on 24 February 2021. Moldova received 21,600 Oxford/AstraZeneca vaccine doses on 27 February from Romania, which started being administered on 2 March. Moldova donated 1,810 of these units to the authorities of the unrecognized state of Transnistria on 5 March, which thanked the Romanian state for the help. Other donations from Romania to Moldova took place on 27 March (50,400 doses) and 7 May (100,800 doses).
The first 14,000-dose batch of the Moderna vaccine arrived in the country on 12 January 2021.The vaccine began to be administered on 4 February.
The Oxford/AstraZeneca vaccine arrived in the country on 7 February, the first 81,000 doses being distributed to regional storage centers during the same day.Until 8 March, the vaccination with Oxford/AstraZeneca was intended only for people aged between 18 and 55 years, on the grounds that in the third phase of Oxford/AstraZeneca's clinical trials too few volunteers over 55 were enrolled; on 8 March, CNCAV dropped the age limit for the administration of this vaccine. On 11 March, CNCAV temporarily quarantined 4,257 doses from Oxford/AstraZeneca's ABV2856 batch as an "extreme precautionary measure", hours after Italy banned use of this same batch following the deaths in Sicily of two men who had been inoculated with doses from it. Romania had received 81,600 doses from the ABV2856 batch and administered most of them. Vaccination with these doses was resumed on 19 March after the European Medicines Agency (EMA) declared the Oxford/AstraZeneca vaccine safe for use. In April, EMA found a possible link between the Oxford/AstraZeneca vaccine and very rare cases of unusual blood clots with low platelet counts, although it said its benefits far outweighed the risks and did not announce any restrictions. As of 4 April, EMA received reports of 222 cases of a rare thrombosis affecting the brain or abdomen among some 34 million people in Europe who have received the Oxford/AstraZeneca jab; most occurred in women under 60 within two weeks of vaccination. As a precaution, several European countries limited the use of the Oxford/AstraZeneca vaccine to older age groups. According to Valeriu Gheorghiță, president of CNCAV, no cases of vaccine-related thrombosis had been confirmed in Romania as of 6 April; he did, however, mention seven cases of unrelated thrombosis in seven people vaccinated against COVID-19, four with Pfizer/BioNTech and three with Oxford/AstraZeneca. On 8 April, CNCAV decided to continue the vaccination with Oxford/AstraZeneca for all age groups.
Valeriu Gheorghiță announced on 9 March that the third phase of vaccination will first start rolling out in the localities with an incidence rate of at least 4.5‰.The people from nine localities – seven county seats (Alba Iulia, Baia Mare, Brașov, Cluj-Napoca, Giurgiu, Timișoara and Zalău), a municipality (Petroșani) and a commune (Sânpetru) – could schedule their appointments on the national vaccination platform before the effective start of the third phase, which was set to begin on 15 March. The authorities introduced waiting lists for appointments, however, without the possibility for people to choose the type of vaccine. In order to optimize the distribution of vaccine doses, it was decided that each vaccination center should inoculate only one type of vaccine.
On 11 March, the one-shot Janssen COVID-19 vaccine became the fourth vaccine to be conditionally approved on the EU level, [ citation needed ]arriving in Romania on 14 April. The 60,000 doses in the first batch remained in storage, as Romanian authorities waited for indications from EMA regarding the safety of the vaccine. In the US, the Centers for Disease Control and Prevention and the Food and Drug Administration recommended a temporary halt on Johnson & Johnson vaccinations in the country after the appearance of six cases of a rare and severe type of blood clot in people inoculated with this vaccine; by mid-April, more than 6.8 million doses of the Janssen vaccine have been administered in the US. EMA finally gave green light to the Janssen vaccine on 20 April, and the first doses began to be distributed to vaccination centers in Romania on 4 May.
In April, family doctors joined the vaccination teams, with first shots being administered in Timiș County.At the beginning of the month, the participation rate among family doctors was about 50–55%. On 17 April, Romania made a new donation to Moldova: 132,000 vaccine units were given to the latter. In an effort to boost rural access to the vaccine, officials launched on 21 April the first mobile vaccination centers in seven counties; in the first phase, mainly Moderna vaccine was distributed in these centers. On 24 April, the first drive-through vaccination center was inaugurated in the parking lot of Deva Shopping City. Between 23 and 26 April, Timișoara Regional Business Center hosted a three-day non-stop vaccination marathon. In the first such action in the country, 6,722 people were vaccinated by more than 500 volunteers. Other vaccination marathons soon followed in Bucharest, Cluj-Napoca, Târgu Mureș and Iași.
In the first weekend of May, walk-in vaccinations were introduced in all centers in the country, with priority for people over 60.Previously, as Oxford/AstraZeneca vaccine stockpiled throughout the country, only people interested in getting this vaccine were able to show up at the vaccination centers without prior appointment. On 2 June, authorities began immunizing children aged 12 to 15 with the Pfizer/BioNTech vaccine. Previously, on 28 May, EMA issued a recommendation for the authorization of the Pfizer/BioNTech vaccine for this age group. In the first week, almost 9,400 12-to-15-year-olds have received the vaccine, most of them in Bucharest.
The Ion Cantacuzino Institute in Bucharest and six military hospitals in the country are the centers where the COVID-19 vaccine is stored, as they have freezers with a large capacity that can ensure storage in the required conditions (e.g., cold chains of −80°C).
Vaccination against COVID-19 in Romania is carried out in three phases, in which priority is given to medical staff, people over 65, people with chronic diseases, people with disabilities, homeless people and essential workers (lawmakers, military personnel, magistrates, teachers, commercial workers, etc.).
|Phase||Priority groups||Number eligible (estimated)|
|I||health and social workers||160,000|
|II||high-risk population||5 million|
|essential workers||1.5 million|
In early March, the Ministry of Health began publishing official data on vaccines administered at each center in the country on the government's open data portal. Data from 27 December 2020 to 5 March 2021 revealed cases of nepotism regarding the vaccination of military personnel and over 7,000 vaccinations ahead of priority groups.Apart from these, local news agencies reported numerous instances of queue-jumping occurring throughout the Romanian healthcare system, as waiting lists were vulnerable to corruption.
Before the official start of the vaccination campaign, the Ministry of Health identified 899 vaccination centers throughout the country: 302 in health units for the immunization of medical staff and 597 in other spaces for phases II and III.583 of them were operational by 30 January 2021. As of 9 March 2021, before the start of the largest phase of the vaccination campaign, 678 vaccination centers with 990 flows were active in the country; according to Valeriu Gheorghiță, the total number of vaccination centers would be 1,137.
As of 10 June 2021, adverse reactions were reported in 16,344 vaccinated people (0.194% or 1.94 reactions at 1,000 doses administered).Most of them were general reactions (fever, headache, myalgia, asthenia, urticaria, etc.). Only six severe allergic reactions were reported as of 10 June 2021. The median age of people who reported adverse reactions was 37; 63% of them were female. By manufacturer, most adverse reactions have been reported in people vaccinated with Oxford/AstraZeneca (0.74% of the total number of doses administered), followed by Moderna (0.29%), Pfizer/BioNTech (0.12%) and Johnson & Johnson (0.09%).
Between 21 December 2020 and 19 March 2021, CNCAV received five reports of death among people who received a COVID-19 vaccine.However, the National Institute of Public Health (INSP) classified them as "coincidences", ruling out any direct link between vaccination and deaths. Moreover, between 1 January and 14 March 2021, INSP recorded 89 deaths (a fatality rate of 0.002% of the people who completed the vaccination scheme) among COVID-19-positive people who previously got vaccinated; 12 of them received both doses.
The following chart shows the total number of doses administered.
The following chart shows the daily number of doses administered, broken down by vaccine manufacturer.
|County||Population||Eligible population||%|| % of eligible|
According to the National Center for Surveillance and Control of Communicable Diseases, between 27 December 2020 and 30 September 2021, 28,929 people (or 0.52% of all people vaccinated with the first dose) tested positive for SARS-CoV-2 after being administered the first dose of vaccine.The median time from the first dose to the date of confirmation was 14 days. During the same period, 38,604 people (or 0.84% of all people vaccinated with both doses) became infected with SARS-CoV-2 after the second dose; most were asymptomatic or mild cases. The median time from the second dose to the date of confirmation was 146 days.
A preliminary analysis of the effectiveness of vaccination against COVID-19 in February–May 2021 showed that full-dose vaccination reduces the risk of death from COVID-19 by 14 times, the risk of hospitalization and ICU admission by 12 times and the risk of SARS-CoV-2 infection by 10 times.
Similar to neighboring countries, a significant portion of the Romanian population is reluctant to get vaccinated. The most commonly cited reasons are fear of adverse reactions and distrust of the vaccine's effectiveness.In September 2020, before the launch of the first anti-COVID-19 vaccine, only 29% of Romanians in urban areas were determined to get vaccinated, but by February 2021, 51% of them said they intended to schedule a vaccination. The vaccination intention was higher among men, people over 45, people with higher education and people with high incomes in urban areas.
In November 2021, Suceava County had the lowest vaccination rate in the country, and the doctor who managed the county's main hospital reported religious influence against vaccination. "Very few [priests] are pro-vaccine, and I definitely know some who are anti-vax," the doctor said. In some cases, a person's "priest, or their pastor, has advised them to not get vaccinated, just like that."
Moldova and Romania have experienced an exceptional relationship since Moldova's independence in 1991. Pan-Romanianism has been a consistent part of Moldovan politics, and was adopted in the Popular Front of Moldova's platform in 1992. Most of Moldova was part of Romania during the Interwar period. The official language of Moldova is Romanian. The peoples of the two countries share common traditions and folklore, including a common name for the monetary unit – the leu. Early signs that Romania and Moldova might unite after both countries achieved emancipation from Soviet rule quickly faded after War of Transnistria. However, a growing unionist sentiment emerged especially in the second decade of the 21st century. While Romania remains interested in Moldovan affairs and its progress towards European integration, a majority of Moldova's population is currently against unification with Romania.
Maia Sandu is a Moldovan politician and the current President of Moldova since 24 December 2020. She is the former leader of the Party of Action and Solidarity (PAS) and former Prime Minister of Moldova from 8 June 2019 until 14 November 2019. On 12 November 2019, Sandu's government collapsed after a vote of no-confidence, with 63 of the 101 MPs having voted on the motion submitted by the PSRM.
The COVID-19 pandemic in Romania is part of the ongoing pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Romania on 26 February 2020, when the first case in Gorj County was confirmed.
The COVID-19 pandemic in Moldova is part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached the Republic of Moldova on 7 March 2020, when a Moldovan woman who returned from Italy tested positive for the novel coronavirus. As the number of infected people started to rise during the next days, the Parliament declared a state of emergency on 17 March 2020 for the entire territory of the Republic of Moldova for a period of 60 days.
Events from the year 2020 in Romania.
Events from the year 2021 in Romania.
Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden, the Public Health Agency has been commissioned by the government to create a vaccination plan. Sveriges riksbank, the central bank of Sweden, predicts that efficient vaccination against COVID-19 has macroeconomic benefits. As of 1 September 2021, 82.0% of adults in Sweden have received at least one dose, with a total of 12,700,896 administered.
The COVID-19 vaccination campaign in Italy is a mass immunization campaign that was put in place by the Italian government in order to respond to the ongoing COVID-19 pandemic. It started on 27 December 2020, together with most countries in the European Union.
The general COVID-19 vaccination in Australia program began on 22 February 2021 in response to the COVID-19 pandemic, and will continue with the goal of vaccinating all willing Australians before 2022. Front-line workers and aged care staff and residents will be the first Australians to be inoculated, before a gradual phased release to less-vulnerable and lower-risk population groups throughout 2021. The Therapeutic Goods Administration (TGA) approved four vaccines for Australian use in 2021: the Pfizer–BioNTech vaccine on 25 January, the Oxford–AstraZeneca vaccine on 16 February, Janssen vaccine on 25 June and the Moderna vaccine on 9 August. Although approved for use, the Janssen vaccine is not included in the Australian vaccination program.
COVID-19 vaccination in France started on 27 December 2020 after the approval of Pfizer/BioNTech vaccine by the European Union commission.
During the COVID-19 pandemic, Romania has supported Moldova on several occasions, supplying it with medical equipment and supplies, volunteer Romanian experts and doctors and even a series of COVID-19 vaccine units that arrived on 27 February 2021, which allowed Moldova to start its vaccination program.
COVID-19 vaccination in Moldova started on 2 March 2021. During the COVID-19 pandemic, Moldova was very reliant on external help from other countries, having received donations of vaccines from Romania, the United Arab Emirates, Russia and China. In fact, Moldova's vaccination campaign started due to a donation from Romania on 27 February 2021 composed of 21,600 Oxford–AstraZeneca COVID-19 vaccine doses, with the first vaccinated person in the country being Alexandru Botizatu. Romania had promised earlier, on 29 December 2020, that it would help Moldova with a collaboration project which would include 200,000 vaccine doses to help Moldova combat the pandemic, but also other matters of the country. Romania subsequently made more donations on 27 March 2021 with 50,400 vaccine units; on 17 April 2021 with 132,000 vaccine doses, fulfilling its promise to Moldova; and on 7 May 2021 with 100,800 vaccine units even though this surpassed the promised 200,000 vaccine doses.
The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination programs have begun in many countries and territories in Africa. As of 5 July 2021, vaccination campaigns had started in 51 African countries with 36.5 million people receiving at least one dose.
COVID-19 vaccination in Mexico is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
The COVID-19 vaccination campaign in Quebec is an ongoing provincial effort to distribute and administer the vaccine against COVID-19.
COVID-19 vaccination in Nigeria is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Vaccination began on 5 March 2021. As of 19 November 2021, 6,021,560 people have received their first dose a COVID-19 vaccine, and 3,369,628 people have received their second dose.
COVID-19 vaccination in Egypt is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.